$2.24 -0.0 -0.4%
Last Trade - 05/03/21
| Market Cap | ÂŁ271.0m |
| Enterprise Value | ÂŁ282.6m |
| Revenue | ÂŁ27.0m |
| Position in Universe | 3755th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.14 | 9.80 | 14.0 | 18.2 | 21.2 | 29.4 | 39.7 | 54.6 | +26.3% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | June 15, 2006 |
| Public Since | August 2, 2013 |
| No. of Shareholders: | 80 |
| No. of Employees: | 113 |
| Sector | Basic Materials |
| Industry | Chemicals |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | 167,478,301 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 1540 Drew Ave, DAVIS, 95618-6320, United States |
| Web | https://www.marronebioinnovations.com/ |
| Phone | +1 530 7502800 |
| Contact | Greg Falesnik (Managing Director (MZ North America)) |
| Auditors | Marcum LLP |
As of 05/03/21, shares in Marrone Bio Innovations Inc are trading at $2.24, giving the company a market capitalisation of ÂŁ271.0m. This share price information is delayed by 15 minutes.
Shares in Marrone Bio Innovations Inc are currently trading at $2.24 and the price has moved by 0.115k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Marrone Bio Innovations Inc price has moved by 69.88% over the past year.
Of the analysts with advisory recommendations for Marrone Bio Innovations Inc, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Marrone Bio Innovations Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Marrone Bio Innovations Inc is scheduled to issue upcoming financial results on the following dates:
Marrone Bio Innovations Inc does not currently pay a dividend.
Marrone Bio Innovations Inc does not currently pay a dividend.
Marrone Bio Innovations Inc does not currently pay a dividend.
To buy shares in Marrone Bio Innovations Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Marrone Bio Innovations Inc are currently trading at $2.24, giving the company a market capitalisation of ÂŁ271.0m.
Here are the trading details for Marrone Bio Innovations Inc:
Based on an overall assessment of its quality, value and momentum, Marrone Bio Innovations Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Marrone Bio Innovations Inc are currently priced at $2.24. At that level they are trading at 14.73% discount to the analyst consensus target price of 0.00.
Analysts covering Marrone Bio Innovations Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.152 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Marrone Bio Innovations Inc. Over the past six months, the relative strength of its shares against the market has been 63.67%. At the current price of $2.24, shares in Marrone Bio Innovations Inc are trading at 65.36% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Marrone Bio Innovations Inc.
Marrone Bio Innovations Inc's management team is headed by:
Here are the top five shareholders of Marrone Bio Innovations Inc based on the size of their shareholding:
